A detailed history of Reuter James Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 6,550 shares of ABBV stock, worth $1.11 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
6,550
Previous 6,144 6.61%
Holding current value
$1.11 Million
Previous $1.05 Million 22.79%
% of portfolio
0.24%
Previous 0.79%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $66,519 - $80,927
406 Added 6.61%
6,550 $1.29 Million
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $48,604 - $56,758
-314 Reduced 4.86%
6,144 $1.05 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $356,238 - $405,900
-2,229 Reduced 25.66%
6,458 $1.18 Million
Q4 2023

Apr 08, 2024

BUY
$137.6 - $154.97 $80,083 - $90,192
582 Added 7.18%
8,687 $1.35 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $28,721 - $33,249
-215 Reduced 2.58%
8,105 $1.21 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $163,119 - $202,991
-1,231 Reduced 12.89%
8,320 $1.12 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $65,942 - $75,942
-456 Reduced 4.56%
9,551 $1.52 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $57,813 - $69,333
-418 Reduced 4.01%
10,007 $1.62 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $96,362 - $110,521
-718 Reduced 6.44%
10,425 $1.4 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $532,864 - $677,445
-3,872 Reduced 25.79%
11,143 $1.71 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $210,508 - $261,181
-1,595 Reduced 9.6%
15,015 $2.43 Million
Q4 2021

Jan 25, 2022

BUY
$107.43 - $135.93 $1.78 Million - $2.26 Million
16,610 New
16,610 $2.25 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Reuter James Wealth Management, LLC Portfolio

Follow Reuter James Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reuter James Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reuter James Wealth Management, LLC with notifications on news.